From: The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma
Patient | Age | Gender | Grade | TNM stage | KRAS status | NRAS status | BRAF status | MSI status | Relative mRNA level | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ENO2 | OGDHL | PKLR | |||||||||
CIMP-high COAD patients | |||||||||||
Pat1 | 63 | F | 2 | T3N1M0 | WT | WT | c. 1799 T → A (p.Val600Glu) | MSI-H | 25↓ | 1.9↑ | 1.1↑ |
Pat2 | 76 | M | 2 | T3N0M0 | WT | WT | c. 1799 T → A (p.Val600Glu) | MSI-H | 25↓ | 2.6↑ | 2.1↑ |
Pat3 | 69 | F | 2 | T3N0M0 | WT | WT | c. 1799 T → A (p.Val600Glu) | MSI-H | 25↓ | 4.0↑ | 2.4↑ |
Pat4 | 62 | F | 2 | T3N1M0 | WT | WT | c. 1799 T → A (p.Val600Glu) | MSI-H | 20↓ | 2.0↑ | 1.4↑ |
Pat5 | 77 | F | 3 | T2N0M0 | WT | WT | c. 1799 T → A (p.Val600Glu) | MSI-H | 1.1↓ | 1.1↑ | 1.3↓ |
Pat6 | 55 | F | 2 | T3N0M0 | WT | WT | c. 1799 T → A (p.Val600Glu) | MSS | 4.3↑ | 2.8↓ | 1.2↑ |
Pat7 | 76 | F | 2 | T3N1M0 | WT | WT | WT | MSS | 2.5↓ | 1.7↑ | 2.4↑ |
Non-CIMP COAD patients | |||||||||||
Pat8 | 85 | M | 2 | T3N0M0 | WT | WT | WT | MSS | 1.1↓ | 3.5↑ | 1.1↓ |
Pat9 | 83 | M | 2 | T3N0M0 | WT | WT | WT | MSS | 7.4↑ | 1.7↑ | 5.1↑ |
Pat10 | 67 | F | 2 | T3N0M0 | WT | WT | WT | MSS | 3.2↑ | 1.0 | 5.7↑ |
Pat11 | 77 | F | 2 | T3N0M0 | WT | WT | WT | MSS | 24.8↑ | 14.3↓ | 10.2↑ |
Pat12 | 59 | F | 3 | T3N1M0 | WT | WT | WT | MSS | 5.7↑ | 4.8↓ | 1.7↓ |
Pat13 | 69 | F | 2 | T4N1M0 | WT | WT | WT | MSS | 3.8↑ | 4.8↓ | 7.7↑ |
Pat14 | 55 | F | 2 | T3N0M0 | WT | WT | WT | MSS | 30.0↑ | 2.9↓ | 13.3↑ |